Capecitabine to Reduce Nonmelanoma Skin Carcinoma Burden in Solid Organ Transplant Recipients

Author： Endrizzi Bart Ahmed Rehana L. Ray Theresa Dudek Arkadiusz Lee Peter

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.39, Iss.4, 2013-04, pp. : 634-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management

By Tessari Gianpaolo Girolomoni Giampiero

Dermatologic Surgery, Vol. 38, Iss. 10, 2012-10 ,pp. : 1622-1630

Elsevier

Access to resources Recommend Favorite

Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach

By Ritchie Simon A. Patel Manisha J. Miller Stanley J.

Dermatologic Surgery, Vol. 38, Iss. 10, 2012-10 ,pp. : 1604-1621

Elsevier

Access to resources Recommend Favorite

Reduction in the Incidence of Squamous Cell Carcinoma in Solid Organ Transplant Recipients Treated with Cyclic Photodynamic Therapy

By WILLEY ANDREA MEHTA SHEETAL LEE PETER K.

Dermatologic Surgery, Vol. 36, Iss. 5, 2010-05 ,pp. : 652-658

Elsevier

Access to resources Recommend Favorite

Valganciclovir: therapeutic role in pediatric solid organ transplant recipients

By Yu Marie A Park Jeong M

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 807-815

Informa Healthcare

Access to resources Recommend Favorite

Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

By Åsberg Anders Rollag Halvor Hartmann Anders

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1159-1166

Informa Healthcare

Access to resources Recommend Favorite